ReviewPediatric nephrology (Berlin, Germany)2026
Pre-transplant evaluation of immunological risk in paediatric kidney transplant recipients.
Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney transplantation is the preferred treatment for children with kidney failure. Clinicians focus on improving graft outcomes by ensuring an optimal immunological environment for recipients. The objective of this review is to provide an overview of the immunological evaluation of a potential paediatric kidney transplant recipient. This review focuses on the role of Human Leucocyte Antigen (HLA) laboratory testing and its clinical applications in the pre-transplant immunological risk assessment for a transplant physician. It provides a basic insight on the current technologies, available tests and their interpretation along with limitations, focusing on HLA antigens and antibodies. It aims to provide a simplified stepwise evaluation of immunological risk factors and encourages regular dialogue with the immunology laboratory personnel.
Indexed as
Identifiers
42878858What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.